11-56252701-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004747.2(OR5T3):c.448C>T(p.Pro150Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,613,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004747.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5T3 | NM_001004747.2 | c.448C>T | p.Pro150Ser | missense_variant | 1/1 | ENST00000313033.4 | NP_001004747.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5T3 | ENST00000313033.4 | c.448C>T | p.Pro150Ser | missense_variant | 1/1 | 6 | NM_001004747.2 | ENSP00000323612.3 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152034Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251234Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135778
GnomAD4 exome AF: 0.000139 AC: 203AN: 1461722Hom.: 0 Cov.: 33 AF XY: 0.000140 AC XY: 102AN XY: 727156
GnomAD4 genome AF: 0.000145 AC: 22AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.502C>T (p.P168S) alteration is located in exon 1 (coding exon 1) of the OR5T3 gene. This alteration results from a C to T substitution at nucleotide position 502, causing the proline (P) at amino acid position 168 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at